Genetic single-nucleotide polymorphisms of inflammation-related factors associated with risk of lung cancer

Medical Oncology

Volumn 30, Issue 1, 2013, Pages

  Bai, Lu ^a   Yu, Hong ^b   Wang, Hetong ^a   Su, Hongxin ^a   Zhao, Junhua ^a   Zhao, Yuxia ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Liaoning Cancer and Institute ^*  (China)

Author keywords

Inflammation; Interleukin 6; Lung cancer; Single nucleotide polymorphism

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; IL6 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; INFLAMMATION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; LUNG TUMOR; MIDDLE AGED; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-6; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; TRANSFORMING GROWTH FACTORS;

MLCS; MLOWN;

EID: 84880579213     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0414-6     Document Type: Article

References (24)

1. Wu X, Zhao H, Suk R, et al. Genetic susceptibility to tobacco-related cancer. Oncogene. 2004;23:6500-23.
2. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452:638-42.
3. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature. 2008;452:633-7.
4. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 2008;40:616-22.
5. Wang Y, Broderick P, Webb E, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet. 2008;40:1407-9.
6. Minna JD. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. J Clin Invest. 2003;111:31-3.
7. Lam DC, Girard L, Ramirez R, et al. Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. Cancer Res. 2007;67:4638-47.
8. Ho YS, Chen CH, Wang YJ, et al. Tobacco-specific carcinogen 4-(methylnitro samino) -1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NfkappaB activation and cyclin D1 up- regulation. Toxicol Appl Pharmacol. 2005;205:133-48.
9. Seitz HK, et al. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem. 2006;387:349-60.
10. Balkwill F, Mantovani A, et al. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539-45.
11. Chen CC, Yang SY, Liu CJ, et al. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol. 2005;34:1310-8.
12. Balkwill F. TNF-α in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25:409-16.
13. Blanco D, Vicent S, Fraga MF, et al. Molecular analysis of a multistep 1ung cancer model induced by chronic inflammation reveals epigenetic regulation of pl6 and activation of the DNA damage response pathway. Neoplasia. 2007;9:840-52.
14. Martey CA, Pollock SJ, Turner CK, et al. Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am J Physiol Lung Cell Mol Physiol. 2004;287:L981-91.
15. Bernert H, Sekikawa K, Radcliffe RA, et al. Tnfa and II-10 deficiencies have contrasting effects on lung tumor susceptibility: gender-dependent modulation of IL-10 haploinsufficiency. Mol Carcinog. 2003;38:117-23.
16. Akira S, Taga T, Kishimoto T. Intereukin-6 in biology and medicine. Adv Immunol. 1993;54:l-78.
17. Lim W-Y, Chen Y, Mohamed Ali S, et al. Polymorphisms in inflammatory pathway genes, host factors and lung cancer risk in Chinese female never-smokers. Carcinogenesis. 2011;32:522-9.
18. Bao S, Yang W, Zhou S, et al. Relationship between single nuelcotide polytmorphisms in-174G/C and-634C/G promoter region of interleukin-6 and prostate cancer. J Huazhong Univ Sci Technolog Med Sci. 2008;28(6):693-6.
19. Zienolddiny S, Ryberg D, Maggini V, et al. Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int J Cancer. 2004;109:353-6.
20. Akhurst RJ. TGF beta signaling in health and disease. Nat Genet. 2004;36:790-2.
21. Sun J, Lei Z, Liu RY, et al. A haplotype of TGFBR1 is predominantly found in non-small cell lung cancer patients displaying TGFBR1 allelic-specific expression. Oncol Rep. 2011;25:685-9.
22. Su D, Ma S, Liu P, et al. Genetic polymorphisms and treatment response in advanced non-small cell lung cancer. Lung Cancer. 2007;56:281-8.
23. Angele S, Romestaing P, Moullan N, et al. ATM haplotypes and cellular response to DNA damage:association with breast cancer risk and clinical radiosensitivity. Cancer Res. 2003;63:8717-25.
24. Zhang L, Yang M, Bi N, et al. ATM polymorphisms are associated with risk of radiation-induced pneumonitis. Int J Radiat Oncol Biol Phys. 2010;77:1360-8.